Company Profile

Actiox LLC
Profile last edited on: 1/19/24      CAGE: 93LK5      UEI: DWURXY4NS9R6

Business Identifier: Multi-tasking wearable designed continuously to monitor glucose, alcohol, and lactate
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2872 Coneflower Street
Thousand Oaks, CA 91360
   (818) 671-9768
Location: Single
Congr. District: 26
County: Ventura

Public Profile

Adapted from NIH Phase I decsription: "Designed for use in various settings, Actiox LLC is indicated as structured around development of a wearable integrated device capable of continuously measuring, recording, and storing ISF alcohol levels in real-time without need for external calibrations. In addition to be cumbersome, currently available transdermal alcohol monitoring devices rely on alcohol detection in sweat or sweat vapor, face significant problems such as long lag times. Addressing these inadequacies, the ActioX, LLC device is described as a non-obtrusive wearable sensor platform to enable pain-free analysis few hundred microns under the skin, directly in the ISF. The novel sensing technology developed by Actiox relies on a biocompatible array of microneedles, optimized for painless skin penetration -- providing continuous access to constantly revitalizing ISF. This fully integrated wirelessly operated device is composed of two components of a reusable electronics and a disposable microneedle array, along with a successful demonstration of a custom- designed app for data capture and visualization. Preliminary data (using the prototype device) showed successful real-time tracking of ISF alcohol in response to alcohol drinking episodes in multiple human subjects, with the results well correlated to those from a breathalyzer. The firm's SBIR Fast-Track project everages this innovative technology to develop a discreet, real-time, continuous, and calibration-free continuous alcohol monitoring device toward prolonged on-body operations to enable more comprehensive and accurate clinical studies and allow efficient control and management of alcohol-related problems, including alcohol use disorder.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Farshad Tehrani -- CEO and Co-Founder

Company News

There are no news available.